Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Silibinin-C-2',3-dihydrogensuccinate, disodium salt

EU orphan designation number: EU/3/10/828   
Active ingredient: Silibinin-C-2',3-dihydrogensuccinate, disodium salt
Indication: Prevention of recurrent hepatitis C in liver transplant recipients
Sponsor: Rottapharm S.p.A
Galleria Unione, 5, 20122 Milan, Italia

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/12/2010 Centralised Orphan - Designation EMA/OD/103/10 (2010)9541 of 17/12/2010